Blog
RSS FeedPosted by Michael Wonder on 12 May 2021
PHARMAC funding 'affects all New Zealanders'
12 May 2021 - Doubling the funding for drug-buying agency PHARMAC will save lives and allow more people to live ...
Posted by Michael Wonder on 12 May 2021
Decision to fund tacrolimus ointment for people with facial eczema
4 May 2021 - PHARMAC is pleased to announce a decision to fund tacrolimus ointment for the treatment of facial ...
Posted by Michael Wonder on 12 May 2021
Impacts to medicine supply from India
12 May 2021 - PHARMAC is in constant contact with our suppliers as the impact of COVID-19 on India unfolds. ...
Posted by Michael Wonder on 11 May 2021
Alberta faces shortage of COVID-19 drug as global demand spikes
11 May 2021 - Provinces with highest case rates hit by shortage of medication for sickest patients. ...
Posted by Michael Wonder on 11 May 2021
Budget 2021–22: generational change and record investment in the health of Australians
11 May 2021 - A joint media release outlining the Morrison Government's $121.4 billion in 2021–22 and $503 billion investment into ...
Posted by Michael Wonder on 11 May 2021
Expensive migraine drug Emgality added to PBS
11 May 2021 - An expensive migraine drug will be listed on the Pharmaceuticals Benefits Scheme, making it affordable for ...
Posted by Michael Wonder on 11 May 2021
Health front and centre of economic recovery
11 May 2021 - Treasurer Josh Frydenberg places the nation’s health, wellbeing and recovery from COVID-19 front and centre of ...
Posted by Michael Wonder on 11 May 2021
FDA grants fast track designation to CERC-002 for treatment of hospitalised patients with COVID-19
11 May 2021 - Cerecor today announced that the U.S. FDA has granted fast track designation to CERC-002 for treatment of ...
Posted by Michael Wonder on 11 May 2021
MHRA approves label extension for Vertex’s Kaftrio combo
11 May 2021 - The UK MHRA has approved a label extension for Vertex’s cystic fibrosis treatment Kaftrio in combination ...
Posted by Michael Wonder on 11 May 2021
BMS withdraws application for Opdivo/Yervoy combination
11 May 2021 - Details revealed in new AusPAR. ...
Posted by Michael Wonder on 10 May 2021
Medicines for colorectal, skin and ovarian cancers approved for NHS Scotland use
10 May 2021 - The Scottish Medicines Consortium accepted a treatment of colorectal cancer in patients with a gene mutation called ...
Posted by Michael Wonder on 10 May 2021
Budget 2021: Alison Day meets with Greg Hunt to help other cancer sufferers
10 May 2021 - Mum of two Alison Day - who has a terminal breast cancer diagnosis - has secured more ...
Posted by Michael Wonder on 10 May 2021
SMC - May 2021 decisions
10 May 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has announced today that ...
Posted by Michael Wonder on 10 May 2021
Smart Immune announces FDA orphan drug status, IND acceptance and fast track designation to commence Phase 1/2 clinical trial of proprietary allogeneic T cell progenitor product SMART 101 (ProTcell) for AML and ALL
10 May 2021 - Phase 1/2 trial to begin by fall 2021 at a top US cancer centre. ...
Posted by Michael Wonder on 10 May 2021
Amgen announces tezepelumab biologics license application submitted to U.S. FDA
10 May 2021 - Potential first in class medicine blocking TSLP, an epithelial sytokine. ...